The Latest Breaking News on Pharma

Is This Biotech Stock a Buy for Under $3?

Biotech company Bionano Genomics (BNGO) has beaten analysts’ top-line estimate in the third quarter. However, its cash and cash equivalents balance has declined year-over-year. Therefore, is it a buy now under $3? Read on to find out….

StockNews.com · Nov 23, 2022

California’s ‘tripledemic’ of viruses is on the rise. Here’s how to care for a sick loved one

Trying to avert a heavy surge in respiratory illnesses, California’s leading public health officials once again stressed on Tuesday that state residents should do all they can to prevent the spread of COVID-19, the flu and respiratory syncytial virus, or RSV, as they gather for the holidays.

Tribune News Service · Nov 23, 2022

Scale of drugs problem contributes to existence of paramilitary groups, MPs told

"The harms of paramilitarism are much broader and will need a tailored and very different process."

Belfast Live · Nov 23, 2022

Britain and South Africa agree health partnership on second day of state visit

Britain and South Africa on Wednesday announced a new health and science partnership to mark the second day of President Cyril Ramaphosa's state visit to London, the first such official guest hosted by Britain's King Charles.

Reuters · Nov 23, 2022

UK and South Africa to strengthen health and climate partnership

The two nations signed an agreement during South African President Cyril Ramaphosa’s state visit to the UK.

The Independent UK · Nov 23, 2022

COVID pill approval ups pandemic arsenal

The health ministry has granted emergency approval for a COVID-19 pill developed by Shionogi Co., opening the door for Japan's first domestically produced oral medicine for the virus to become available as soon as early December.

The Japan News/Yomiuri · Nov 23, 2022

Odisha launches Amlan to reduce anaemia

BHUBANESWAR: The Odisha government on Wednesday launched Anaemia Mukta Lakhya Abhiyan (Amlan), a multi-departmental campaign to reduce anaemia or haemoglobin deficiency in the state.

The Times of India · Nov 23, 2022

The growing menopause-at-work market

Little discussed and poorly understood, menopause — and the market for helping treat its accompanying symptoms — is gaining more attention when it comes to employer benefits.

Axios · Nov 23, 2022

Who can get an autumn Covid booster jab and how do I book?

Booster vaccinations are being offered to everyone in England over the age of 50

The Independent UK · Nov 23, 2022

New clinical trial will test whether infections need antibiotics

At present, medics may sometimes give out antibiotics unnecessarily because it is not clear whether an infection is caused by bacteria

Wales Online · Nov 23, 2022